查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1356847

MRD 检测市场报告：2030 年趋势、预测与竞争分析

MRD Testing Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

MRD 检测趋势和预测

到 2030 年，全球 MRD 检测市场预计将达到 44 亿美元，2024 年至 2030 年年复合成长率为 12.8%。这个市场的主要促进因素是血液相关癌症的增加、全球老年人口的增加以及微量残存疾病（MRD）检测技术的进步。全球MRD检测市场前景广阔，医院、专科诊所、诊断实验室、学术和研究机构市场蕴藏商机。

MRD 检测市场洞察

Lucintel 预测聚合酶炼式反应 (PCR) 将在预测期内达到最高成长。

在这个市场中，医院和专科诊所将继续成为最大的细分市场。

预计亚太地区在预测期内将出现最高成长。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要要素有哪些？市场的主要挑战和业务风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些，由于材料或产品替代导致市场占有率下降的威胁有多大？
  • Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

目录

第1章执行摘要

第2章全球 MRD 检测市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业促进因素与挑战

第3章2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球MRD检测市场趋势（2018-2023）与预测（2024-2030）
  • 按技术分類的全球 MRD 检测市场
    • 流式细胞仪
    • 聚合酶炼式反应 (PCR)
    • 下一代定序（NGS）
    • 其他的
  • 全球 MRD 检测市场（按应用）
    • 骨髓恶性肿瘤
    • 白血病
    • 淋巴瘤
    • 固态肿瘤
    • 其他的
  • 按最终用途行业分類的全球 MRD 检测市场
    • 医院和专科诊所
    • 诊断实验室
    • 学术研究所
    • 其他的

第4章2018-2030年分地区市场趋势及预测分析

  • 全球 MRD 检测市场（按地区）
  • 北美MRD检查市场
  • 欧洲MRD检测市场
  • 亚太地区MRD检测市场
  • 其他地区MRD检测市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 全球 MRD 检测市场成长机会（按技术）
    • 全球 MRD 检测市场成长机会（按应用）
    • 全球 MRD 检测市场成长机会（依最终用途产业）
    • 全球 MRD 检测市场成长机会（按地区）
  • 全球MRD检测市场新趋势
  • 战略分析
    • 新产品开发
    • 扩大全球 MRD 检测市场的产能
    • 全球MRD检测市场的合併、收购与合资
    • 认证和许可

第7章主要企业概况

  • Labcorp
  • F. Hoffmann-La Roche
  • Guardant Health
  • Sysmex Corporation
  • NeoGenomics Laboratories
  • Adaptive Biotechnologies Corporation
  • ArcherDX
  • Asuragen
  • Arup Laboratories
简介目录

MRD Testing Trends and Forecast

The future of the global MRD testing market looks promising with opportunities in the hospitals and specialty clinic, diagnostic laboratory, and academic & research institutes markets. The global MRD testing market is expected to reach an estimated $4.4 billion by 2030 with a CAGR of 12.8% from 2024 to 2030. The major drivers for this market are increasing occurrence of blood-related cancers, growing global elderly population, and progress in technology for minimal residual disease (MRD) testing.

A more than 150-page report is developed to help in your business decisions.

MRD Testing by Segment

The study includes a forecast for the global MRD testing by technology, application, end use industry, and region.

MRD Testing Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

  • Flow Cytometry
  • Polymerase Chain Reaction (PCR)
  • Next-Generation Sequencing (NGS)
  • Others

MRD Testing Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Hematological Malignancies
  • Leukemia
  • Lymphoma
  • Solid Tumors
  • Others

MRD Testing Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals and Specialty Clinics
  • Diagnostic Laboratories
  • Academic & Research Institutes
  • Others

MRD Testing Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of MRD Testing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies MRD testing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the MRD testing companies profiled in this report include-

  • Labcorp
  • F. Hoffmann-La Roche
  • Guardant Health
  • Sysmex Corporation
  • Neogenomics Laboratories
  • Adaptive Biotechnologies Corporation
  • Archerdx
  • Asuragen
  • Arup Laboratories

MRD Testing Market Insights

Lucintel forecasts that Polymerase Chain Reaction (PCR) is expected to witness highest growth over the forecast period.

Within this market, hospitals and specialty clinics will remain the largest segment.

APAC is expected to witness highest growth over the forecast period.

Features of the Global MRD Testing Market

Market Size Estimates: MRD testing market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: MRD testing market size by various segments, such as by application, end use industry, and region. in terms of value ($B).

Regional Analysis: MRD testing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different technologies, applications, end use industries, and region.s for the MRD testing market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the MRD testing market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the MRD testing market size?

Answer: The global MRD testing market is expected to reach an estimated $4.4 billion by 2030.

Q.2. What is the growth forecast for MRD testing market?

Answer: The global MRD testing market is expected to grow with a CAGR of 12.8% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the MRD testing market?

Answer: The major drivers for this market are increasing occurrence of blood-related cancers, growing global elderly population, and progress in technology for minimal residual disease (MRD) testing.

Q.4. What are the major segments for MRD testing market?

Answer: The future of the global MRD testing market looks promising with opportunities in the hospitals and specialty clinic, diagnostic laboratory, and academic & research institutes markets.

Q.5. Who are the key MRD testing market companies?

Answer: Some of the key MRD testing companies are as follows:

  • Labcorp
  • F. Hoffmann-La Roche
  • Guardant Health
  • Sysmex Corporation
  • NeoGenomics Laboratories
  • Adaptive Biotechnologies Corporation
  • ArcherDX
  • Asuragen
  • Arup Laboratories

Q.6. Which MRD testing market segment will be the largest in future?

Answer: Lucintel forecasts that next-generation sequencing (NGS) is expected to witness highest growth over the forecast period.

Q.7. In MRD testing market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the MRD testing market by technology (flow cytometry, polymerase chain reaction (PCR), next-generation sequencing (NGS), and others), application (hematological malignancies, leukemia, lymphoma, solid tumors, and others), end use industry (hospitals and specialty clinics, diagnostic laboratories, academic & research institutes, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global MRD Testing Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global MRD Testing Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global MRD Testing Market by Technology
    • 3.3.1: Flow Cytometry
    • 3.3.2: Polymerase Chain Reaction (PCR)
    • 3.3.3: Next-Generation Sequencing (NGS)
    • 3.3.4: Others
  • 3.4: Global MRD Testing Market by Application
    • 3.4.1: Hematological Malignancies
    • 3.4.2: Leukemia
    • 3.4.3: Lymphoma
    • 3.4.4: Solid Tumors
    • 3.4.5: Others
  • 3.5: Global MRD Testing Market by End Use Industry
    • 3.5.1: Hospitals and Specialty Clinics
    • 3.5.2: Diagnostic Laboratories
    • 3.5.3: Academic & Research Institutes
    • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global MRD Testing Market by Region
  • 4.2: North American MRD Testing Market
    • 4.2.2: North American MRD Testing Market by End Use Industry: Hospitals and Specialty Clinics, Diagnostic Laboratories, Academic & Research Institutes, and Others
  • 4.3: European MRD Testing Market
    • 4.3.1: European MRD Testing Market by Technology: Flow Cytometry, Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), and Others
    • 4.3.2: European MRD Testing Market by End Use Industry: Hospitals and Specialty Clinics, Diagnostic Laboratories, Academic & Research Institutes, and Others
  • 4.4: APAC MRD Testing Market
    • 4.4.1: APAC MRD Testing Market by Technology: Flow Cytometry, Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), and Others
    • 4.4.2: APAC MRD Testing Market by End Use Industry: Hospitals and Specialty Clinics, Diagnostic Laboratories, Academic & Research Institutes, and Others
  • 4.5: ROW MRD Testing Market
    • 4.5.1: ROW MRD Testing Market by Technology: Flow Cytometry, Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), and Others
    • 4.5.2: ROW MRD Testing Market by End Use Industry: Hospitals and Specialty Clinics, Diagnostic Laboratories, Academic & Research Institutes, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global MRD Testing Market by Technology
    • 6.1.2: Growth Opportunities for the Global MRD Testing Market by Application
    • 6.1.3: Growth Opportunities for the Global MRD Testing Market by End Use Industry
    • 6.1.4: Growth Opportunities for the Global MRD Testing Market by Region
  • 6.2: Emerging Trends in the Global MRD Testing Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global MRD Testing Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global MRD Testing Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Labcorp
  • 7.2: F. Hoffmann-La Roche
  • 7.3: Guardant Health
  • 7.4: Sysmex Corporation
  • 7.5: NeoGenomics Laboratories
  • 7.6: Adaptive Biotechnologies Corporation
  • 7.7: ArcherDX
  • 7.8: Asuragen
  • 7.9: Arup Laboratories